跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,347 条关于
“complement C5”
全部
1,347
临床试验
327
药物
68
机构
2
资讯
950
去年
Astellas Withdraws European Application for Avacincaptad Pegol in Geographic Atrophy
去年
ImmunAbs Receives FDA Clearance for Phase 2 Trial of IM-101 Complement Inhibitor in Myasthenia Gravis
去年
Regeneron's Pozelimab and Cemdisiran Combo Shows Promise in PNH Phase 3 Trial
去年
Astellas Withdraws EU Application for Geographic Atrophy Drug Avacincaptad Pegol
7个月前
EMA Initiates Data Integrity Review of Amgen's Tavneos Following Concerns Over Pivotal ADVOCATE Study
去年
Astellas Seeks First Japanese Approval for Geographic Atrophy Treatment with Avacincaptad Pegol
去年
FDA Initiates Review of Roche's Monthly Injectable Crovalimab for Rare Blood Disorder PNH
去年
FDA Blocks Approval of AstraZeneca's Ultomiris for Neuromyelitis Optica Spectrum Disorder
去年
Zilucoplan Shows Sustained Efficacy and Steroid-Sparing Benefits in Long-Term Myasthenia Gravis Treatment
去年
Zilbrysq Market Projected to Grow 21.64% Annually Through 2030 Following FDA Approval for Myasthenia Gravis
第 1 页,共 95 页
上一页
下一页